Understanding and Treatment for Anxiety Disorders
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".
Deadline for manuscript submissions: closed (31 July 2020) | Viewed by 23409
Special Issue Editor
2. Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
Interests: epidemiology; aging; mental health; cognitive function; lifetime perspective; depression; anxiety
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Anxiety disorders are among one of the most prevalent mental conditions, accounting for up to 13% of disability worldwide. It is estimated that more than 260 million people are affected by anxiety. Untreated anxiety disorders tend to be chronic, and they are often risk factors for latter depression and substance abuse. They usually start early in life, especially phobias and separation anxiety, with the highest incidence risk between 6 and 17 years of age. Epidemiological studies show that, in general, anxiety disorders are more prevalent at younger ages than in older adults, although recent studies suggest that the presence of anxiety late in life might be associated with an increased risk for dementia. Additionally, anxiety disorders are more difficult to diagnose and treat in older adults and are typically related to psychiatric and medical comorbidities.
The presence of anxiety disorders has been consistently shown to be linked to increased personal and societal costs, frequent outpatient and emergency service visits, loss of labour productivity, unemployment and social impairment. They have also been associated with poor quality of life and an increased risk for disability and premature death. Early preventive programs delivered during childhood and adolescence appear as a potentially effective tool to reduce anxiety-related impairment and the risk of future mental health problems. Cognitive behavioural therapy is often one of the first-line treatments for certain anxiety disorders, whereas pharmacological treatment usually includes antidepressants as one of the first-line therapeutic options.
A considerable amount of literature addressing anxiety disorders has been published during the last few decades. Still, there are several questions that need to be addressed. This Special Issue is devoted to advancing the understanding of anxiety disorders from a lifetime perspective. This includes improvement of diagnosis and early detection of anxiety disorders, taking into account different periods of life and cultural factors, and categorical or dimensional approaches; determining which factors impact the trajectories of anxiety disorders (which includes prognosis of the disease, course and relapses) using a longitudinal perspective; and understanding the underlying mechanisms that contribute to vulnerability to anxiety disorders. Additionally, this Special Issue is intended to explore potential new therapies for anxiety disorders, considering preventive programs delivered early in life, and effective and lasting treatments, both psychological and biological, with special attention to new ways to deliver these interventions (e.g., computed-assisted, Internet-based and app treatments).
Dr. Beatriz Olaya
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anxiety disorders
- lifetime
- epidemiology
- treatment
- prevention
- risk factors
- comorbidity
- diagnosis
- Internet-based interventions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
